A Study of the Relationship of Gut Microbial Composition and Stroke Outcome
NCT03470506 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2019-11-19
Summary
The purpose of this study is to investigate the relationship between gut microbiome (bacteria in the gut), inflammation and the injured brain. It has been established that bacteria in the gut play key roles in digestion, nutrition absorption and immune response of the entire body. Human intestinal bacteria composition in the gut has been associated with several stroke risk factors including obesity, insulin resistance, diabetes and hypertension. If we can establish a relationship between gastrointestinal microbial community composition and ischemic stroke outcomes could lead to dietary interventions in the future to improve recovery after a stroke.
Conditions
Interventions
- OTHER
-
Stool Samples
Stool samples will be collected at baseline and 3 months to assess differences in microbiome composition between groups
Sponsors & Collaborators
-
University of Colorado, Denver
collaborator OTHER -
University of Virginia
lead OTHER
Principal Investigators
-
Bradford Worrall, MD, MS · University of Virginia
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-20
- Primary Completion
- 2022-01-06
- Completion
- 2022-07-01
Countries
- United States
Study Locations
More Related Trials
-
FMT in Uncomplicated Diverticulitis
NCT05373784 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Gut Microbiota Changes After Fecal Microbiota Transplantation
NCT02557685 ·Status: UNKNOWN ·Phase: PHASE2
-
Networks of Bacterium-Metabolite Interactions in the Small Intestine
NCT04978077 ·Status: TERMINATED ·Phase: NA
-
Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
NCT02269150 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
NCT03353506 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Fecal Therapy
NCT02046525 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
NCT04679324 ·Status: WITHDRAWN
-
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
NCT00304876 ·Status: COMPLETED
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
A Study to Evaluate the Influence of Diet on GI Health
NCT04783142 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD)
NCT03548051 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection
NCT02403622 ·Status: TERMINATED ·Phase: PHASE2
-
Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection
NCT04885946 ·Status: UNKNOWN ·Phase: NA
-
Early FMT for C.Difficile
NCT02465463 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Explore the Role of Gut Flora in COVID-19 Infection
NCT04359836 ·Status: RECRUITING
-
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
NCT01259726 ·Status: COMPLETED ·Phase: PHASE2
-
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
NCT07261826 ·Status: RECRUITING
-
Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics
NCT03117582 ·Status: COMPLETED
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplant for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated Inoculum
NCT01914731 ·Status: COMPLETED ·Phase: PHASE1
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
NCT02686645 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Fecal Microbiota Transplant
NCT04090346 ·Status: COMPLETED ·Phase: PHASE4
-
Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection
NCT02148601 ·Status: COMPLETED ·Phase: PHASE2
-
Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation
NCT05739825 ·Status: RECRUITING
-
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
NCT01322386 ·Status: COMPLETED ·Phase: PHASE1